Researchers identify a potential new therapeutic target for E. coli infections

March 28, 2013
Researchers identify a potential new therapeutic target for E. coli infections
Virginia Bioinformatics Institute researchers study how various bacteria cause health problems in people and animals.

(Medical Xpress)—A new study by researchers at the Center for Modeling Immunity to Enteric Pathogens at Virginia Bioinformatics Institute provides novel insight into how an emerging strain of the diarrhea-causing bacteria E. coli interacts with its host.

The discovery about enteroaggregative Escherichia coli (EAEC) could be used by scientists to devise new therapeutic strategies against the disease. The study was published recently in PLOS One.

EAEC infection is the most common cause of persistent diarrhea worldwide and is most frequently seen in living in developing countries. Because these children are unable to mount an effective immune response to the bacteria, the infection often persists once it gains a foothold. A 2011 outbreak in northern Germany received international attention when it sickened more than 3,000 people, causing 53 deaths.

"In many parts of the world, the relationship between infection and malnutrition is a vicious cycle. For example, malnourished EAEC-infected individuals experience a chronic burden linked to . Our study in mice suggests that promoting inflammation may help clear the bacterial infection soon after infection," said Josep Bassaganya-Riera, a professor of immunology, director of the Nutritional Immunology and Laboratory, and the principal investigator of the center.

The MIEP team created a of the infection to investigate host–bacteria interactions. Previous studies have shown that activation of PPAR γ, a protein that aids in metabolic regulation, plays a crucial role in suppressing inflammation and regulating immune responses. When investigators blocked the function of the protein in EAEC-infected mice, they observed that the animals developed a faster and more effective defense against the disease.

"Pharmacological inhibition of PPAR γ reduced disease and bowel pathology following infection by inducing potent . Protective immune responses to EAEC are characterized by the predominance of effector T helper 17 cells that promote antimicrobial immunity and bacterial clearance," said Raquel Hontecillas, associate director of MIEP and lead investigator of the EAEC project.

Studying the bacteria and the ways in which PPAR γ can modulate immune responses in the gut may help researchers develop new to address such debilitating infections. This new work has enabled the MIEP team to test new therapies that may promote bacterial clearance. The Center for Modeling Immunity to Enteric Pathogens is funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, under Contract No. HHSN272201000056C.

Explore further: Chronic infection may add to developing-world deaths

More information: www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0057812

Related Stories

Chronic infection may add to developing-world deaths

February 12, 2009

Worldwide, nearly 2 million people per year die from diarrhea, the vast majority of them in poor countries in Africa and Asia. The disease accounts for 18 percent of all deaths among children — and yet is almost always ...

Botanical compound could prove crucial to healing influenza

July 18, 2012

Building on previous work with the botanical abscisic acida, researchers in the Nutritional Immunology and Molecular Medicine Laboratory (NIMML) have discovered that abscisic acid has anti-inflammatory effects in the lungs ...

C. diff scientists reveal potential target to fight infections

November 30, 2012

Researchers at Virginia Bioinformatics Institute at Virginia Tech have discovered how a common diarrhea-causing bacterium sends the body's natural defenses into overdrive, actually intensifying illness while fighting infection.

Recommended for you

Basic research fuels advanced discovery

August 26, 2016

Clinical trials and translational medicine have certainly given people hope and rapid pathways to cures for some of mankind's most troublesome diseases, but now is not the time to overlook the power of basic research, says ...

New method creates endless supply of kidney precursor cells

August 25, 2016

Salk Institute scientists have discovered the holy grail of endless youthfulness—at least when it comes to one type of human kidney precursor cell. Previous attempts to maintain cultures of the so-called nephron progenitor ...

New avenue for understanding cause of common diseases

August 25, 2016

A ground-breaking Auckland study could lead to discoveries about many common diseases such as diabetes, cancer and dementia. The new finding could also illuminate the broader role of the enigmatic mitochondria in human development.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.